The Case Western Reserve Clinical Trials Unit is currently enrolling healthy, HIV-negative women and men, ages 18-50, in an HIV prevention vaccine trial, sponsored by the National Institutes of Health. The study is enrolling 101 participants in 5 cities.
This trial is not asking whether the vaccines work as HIV prevention, so the people joining the trial do not have to be at risk for HIV infection.
There are two vaccines involved in this placebo-controlled trial. The vaccines are not made from HIV and cannot cause HIV infection.
There are 8 or 10 clinic visits in this trial over 6 to 12 months, depending on which group you are randomized into. Vaccinations are given at the first visit.
Compensation is provided.
We would be happy to answer any questions you may have.